Jeffrey Allen Bailey Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity
Jeffrey Allen Bailey is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 25,491 shares of AUPH, which is worth approximately $225,850. The most recent transaction as insider was on Nov 21, 2024, when has been sold 12,135 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
25.5K
n/a
3M change
n/a
12M change
Total Value Held
$225,850
Jeffrey Allen Bailey Transaction History
Also insider at
JAB
Jeffrey Allen Bailey
Director
Boston, MA